Effect of antisense oligodeoxynucleotide of vascular endothelial growth factor C on lymphangiogenesis and angiogenesis of pancreatic cancer

Abstract

In order to investigate the effect of antisense oligonucleotide (ASODN) of vascular endothelial growth factor C (VEGF-C) on lymphangiogenesis and angiogenesis of pancreatic cancer, antisense and scamble-sense oligonucleotide of VEGF-C were constructed, and the model of nude mice with orthotopically xenografted human pancreatic cancer cells (Panc-1) was established. Thirty nude mice were randomly divided into 3 groups: PBS control group (group A), scramble-sense control group (group B) and antisense group (group C). All nude mice were treated once every 2 days as 3 times per week, for 3 weeks (oligonucleotide 10 mg/kg every time). After treatments were completed, ELISA method was used to examine the concentration of VEGF-C in plasma and immunohistochemical method to examine microvessel density (MVD), lymphtic vessel density (LVD) of pancreatic cancer. The results showed that the expression of VEGF-C was inhibited significantly in group C. The concentrations were 237.5±41.5, 221.5±52.3 and 108.6±14.9 pg/mL in groups A, B and C respectively (P<0.01). LVD in groups A, B and C was 13.8±2.1, 12.4±1.9 and 4.2±1.6 respectively (P<0.01). MVD in groups A, B and C was 27.5±8.7, 25.9±4.2 and 19.4±5.6 respectively with no significant difference among the groups (P>0.05). It was suggested that VEGF-C ASODN decreased the expression levels of VEGF-C in nude mice with orthotopically xenografted human pancreatic cancer, and it could inhibit lymphangiogenesis, but had no significant effect on angiogenesis.

Keywords

pancreatic cancer / vascular endothelial growth factor C / lymphangiogenesis / angiogenesis / gene therapy

References

[1] TangR. F., ItakuraJ., AikawaT., et al.. Overexpression of lymphangiogenic growth factor VEGF-C in human pancreatic cancer. Pancreas, 2001, 22(3): 285-292

[2] SkobeM., HambergL. M., AlitaloK., et al.. Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. Am J Pathol, 2001, 159: 893-903

[3] WeidnerN.. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol, 1995, 147: 9-19

[4] LiK., TaoJ., WangC. Y.. Expression of vascular endothelial growth factor C and its correlation with lymphangiogenesis in pancreatic carcinoma. Chin J Exp Surg (Chinese), 2006, 23: 16-17

[5] BergerA. C., WatsonJ. C., RoseE. A., et al.. The meastatic/examined lymph node ratio is an important progonostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am Surg, 2004, 70: 235-240

[6] JoukovV., SorsaR., AlitaloK., et al.. Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO, 1997, 16(13): 3898-3911

[7] HotzH. G., HinesO. J., MasoodR., et al.. VEGF antisense therapy inhibits tumor growth and improves survival in experimental pancreatic cancer. Surgery, 2005, 137(2): 192-199

[8] DassC. Rl.. Liposome-mediated delivery of oligodeoxynucleotides in vivo. Drug Delivery, 2002, 9(3): 169-180